← Open Payments lookup

JOSEPHINE KARL: Open Payments

NPI 1316051071 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,740 in 180 payments from 21 companies in 2025. Trend: 2023 $4,103 · 2024 $4,003 · 2025 $3,740

Food & beverage: $3,574Education: $165
CompanyPaymentsAmount
UCB, Inc.25$530
Regeneron Healthcare Solutions, Inc.17$495
GENZYME CORPORATION15$487
ABBVIE INC.29$451
Janssen Biotech, Inc.12$289
Amgen Inc.11$251
SUN PHARMACEUTICAL INDUSTRIES INC.13$191
Incyte Corporation9$177
Novartis Pharmaceuticals Corporation7$137
Ortho Dermatologics, a division of Bausch Health US, LLC13$136

Products named: DUPIXENT, Bimzelx, TREMFYA, Otezla, SKYRIZI, OPZELURA, Cabtreo, RINVOQ.

Industry payments across TX — which companies pay providers there.